Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
February 25, 2020
Patent Application Number
15748557
Date Filed
July 28, 2016
Patent Citations Received
Patent Primary Examiner
Patent abstract
Inhibitor compounds are disclosed. The compounds are effective in the treatment of diseases or conditions in which interleukin 1 β activity is implicated. Methods of synthesis of the compounds, as well as pharmaceutical compositions comprising the compounds are also disclosed.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
